Pirouette Pharma

Portsmouth, NH · Founded 2017 · Privately Held (backing)

Developer of automated injectors designed for the emergency treatment of severe allergic reactions. Pirouette Pharma is based in Portsmouth, NH and was founded in 2017. It was valued at $95 million at its Equity Crowdfunding in Feb 2026, the last priced event on record. It has raised $22.9 million across 2 recorded rounds; the latest was a $1.1 million seed round in Mar 2026.

PMV mark · valuation
$95.0M
Oct 2026
Priced at
its Equity Crowdfunding
Feb 2026
Total raised
$22.9M
Last round
Seed Round
Mar 2026
What is Pirouette Pharma worth?
$95.0MPrivateMarketView mark · Oct 2026

Valued at $95.0M at its Equity Crowdfunding, Feb 2026. Nothing has traded since.

Free account
More of Pirouette Pharma with a free account
  • ·The complete investor list: 20 names
  • ·Watch Pirouette Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Pirouette Pharma funding history

2 rounds
DateRoundRaisedPost-money
Mar 2026Seed Round$1.1M▮
Mar 2025Seed Round$2.4M▮
Unlock post-money valuations

Membership and data by Private Market View

Pirouette Pharma valuation

Pirouette Pharma was valued at $95 million at its Equity Crowdfunding in Feb 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Pirouette Pharma raised?

Pirouette Pharma has raised $22.9 million in total; 2 of its rounds are on record. The largest on record was a $2.4 million seed round in Mar 2025; the most recent was a $1.1 million seed round in Mar 2026.

Pirouette Pharma has filed 1 Form D with the SEC, most recently in Apr 2025 ($2.4 million sold to 1 investor).

How Pirouette Pharma's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pirouette Pharma, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Pirouette Pharma

What is Pirouette Pharma worth?
Pirouette Pharma is valued at $95.0M as of Oct 2026. Valued at $95.0M at its Equity Crowdfunding, Feb 2026. Nothing has traded since.
How much has Pirouette Pharma raised?
Pirouette Pharma has raised $22.9M in total funding across 2 recorded rounds.
When did Pirouette Pharma last raise?
Pirouette Pharma last raised in Mar 2026 (Seed Round), raising $1.1M.